ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

LIFE aTyr Pharma Inc

1.90
0.00 (0.00%)
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
aTyr Pharma Inc LIFE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.90 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.90
more quote information »

Recent News

Date Time Source Heading
06/6/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:00GLOBEaTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from..
30/5/202406:03EDGAR2Form 8-K - Current report
25/5/202406:00GLOBEaTyr Pharma Announces Inducement Grants Under Nasdaq Listing..
24/5/202409:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202409:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202409:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202421:00GLOBEaTyr Pharma to Present Poster Describing Efzofitimod’s..
14/5/202422:00GLOBEaTyr Pharma Announces Second Positive DSMB Review for..
06/5/202422:00GLOBEaTyr Pharma to Present at Upcoming Investor Conferences
03/5/202406:00GLOBEaTyr Pharma Announces First Quarter 2024 Results and..
01/4/202423:00GLOBEaTyr Pharma to Participate in April Investor Conferences
15/3/202407:00GLOBEaTyr Pharma Announces Fourth Quarter and Full Year 2023..
29/2/202400:00GLOBEaTyr Pharma to Webcast Conference Call Reporting Fourth..
22/2/202400:00GLOBEaTyr Pharma Announces Expanded Access Program (EAP) for..
07/2/202412:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202412:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202400:00GLOBEaTyr Pharma to Present Posters Highlighting Importance of..
19/1/202400:00GLOBEaTyr Pharma Announces Howard University President Emeritus..
10/1/202411:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202411:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202404:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/12/202310:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202308:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:00GLOBEaTyr Pharma Presents Poster Demonstrating Preclinical..
10/11/202309:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10/11/202308:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202308:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:06EDGAR2Form 8-K - Current report
10/11/202308:00GLOBEaTyr Pharma Announces Third Quarter 2023 Results and..
01/11/202323:00GLOBEaTyr Pharma to Present at November Investor Conferences
31/10/202323:00GLOBEaTyr Pharma Announces Dosing of First Patient in Phase 2..
26/9/202323:01EDGAR2Form 8-K - Current report
11/9/202322:04EDGAR2Form 8-K - Current report
11/9/202322:00GLOBEaTyr Pharma Presents Efzofitimod Data Demonstrating..
24/8/202322:00GLOBEaTyr Pharma to Present at the H.C. Wainwright 25th Annual..
11/8/202306:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:10EDGAR2Form 8-K - Current report
10/8/202306:00GLOBEaTyr Pharma Announces Second Quarter 2023 Results and..
02/8/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/6/202322:00GLOBEEuropean Commission Grants Orphan Drug Designation for aTyr..
20/6/202322:00GLOBEaTyr Pharma to Present on Lead Therapeutic Candidate..
10/6/202306:00GLOBEaTyr Pharma Announces Inducement Grants Under Nasdaq Listing..

Your Recent History

Delayed Upgrade Clock